NEUMORA THERAPEUTICS, INC. EXECUTIVE CHAIRMAN AGREEMENTExecutive Chairman Agreement • August 25th, 2023 • Neumora Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 25th, 2023 Company Industry JurisdictionTHIS EXECUTIVE CHAIRMAN AGREEMENT (this “Agreement”) is made and entered into effective as of July 3, 2023 (the “Effective Date”), by and between Neumora Therapeutics, Inc., a Delaware corporation (the “Company”), and Paul L. Berns, an individual (the “Chairman”).
NEUMORA THERAPEUTICS, INC. EXECUTIVE CHAIRMAN AGREEMENTExecutive Chairman Agreement • August 9th, 2023 • Neumora Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 9th, 2023 Company Industry JurisdictionTHIS EXECUTIVE CHAIRMAN AGREEMENT (this “Agreement”) is made and entered into effective as of July 3, 2023 (the “Effective Date”), by and between Neumora Therapeutics, Inc., a Delaware corporation (the “Company”), and Paul L. Berns, an individual (the “Chairman”).